Further studies reported that KLC2-MT augmented signal transducer and activator of transcription 3 (STAT3) activation and nuclear accumulation in imatinib-treated CML cells. Here, STAT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.